Consensus Update for Systemic Treatment of Atopic Dermatitis

키워드

참고문헌 (136)

1. 이지현, "A Comprehensive Review of the Treatment of Atopic Eczema", Allergy, Asthma & Immunology Research, 8(3), pp.181~190 (2016), 대한천식알레르기학회
2. 이지현, "Prevalence of Atopic Dermatitis in Korean Children Based on Data From the 2008-2011 Korean National Health and Nutrition Examination Survey", Allergy, Asthma & Immunology Research, 8(1), pp.79~83 (2016), 대한천식알레르기학회
3. 김정은, "2019 Consensus Korean Diagnostic Guidelines to Define Severity Classification and Treatment Refractoriness for Atopic Dermatitis: Objective and Subjective Assessment of Severity", Annals of Dermatology, 31(6), pp.654~661 (2019), 대한피부과학회[DOI]
4. 김정은, "Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment", Annals of Dermatology, 27(5), pp.578~592 (2015), 대한피부과학회
5. Drucker AM, "Use of systemic corticosteroids for atopic dermatitis : international eczema council consensus statement", Br J Dermatol, 178, pp.768~775 (2018)
6. Heddle RJ, "Combined oral and nasal beclomethasone diproprionate in children with atopic eczema:a randomised controlled trial", Br Med J (Clin Res Ed), 289, pp.651~654 (1984)
7. La Rosa M, "A randomized, double-blind, placebo-controlled, crossover trial of systemic flunisolide in the treatment of children with severe atopic dermatitis", Curr Ther Res, 56, pp.720~726 (1995)
8. Calzavara Pinton P, "Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA)", G Ital Dermatol Venereol, 153, pp.133~145 (2018)
9. Roekevisch E, "Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis : a systematic review", J Allergy Clin Immunol, 133, pp.429~438 (2014)
10. Sidbury R, "Guidelines of care for the management of atopic dermatitis:section 3. Management and treatment with phototherapy and systemic agents", J Am Acad Dermatol, 71, pp.327~349 (2014)
11. Yu SH, "A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis", J Am Acad Dermatol, 78, pp.733~740 (2018)
12. Schmitt J, "Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre tria", Br J Dermatol, 162, pp.661~668 (2010)
13. Munro CS, "Maintenance treatment with cyclosporin in atopic eczema", Br J Dermatol, 130, pp.376~380 (1994)
14. Sowden JM, "Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis", Lancet, 338, pp.137~140 (1991)
15. van Joost T, "Cyclosporin in atopic dermatitis : a multicentre placebocontrolled study", Br J Dermatol, 130, pp.634~640 (1994)
16. Zonneveld IM, "The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis : a comparison of two dosage regimens", Br J Dermatol, 135(Suppl 48), pp.15~20 (1996)
17. 허식, "The Efficacy and Safety of Long-term Oral Cyclosporine Treatment for Patients with Atopic Dermatitis", Annals of Dermatology, 22(1), pp.9~15 (2010), 대한피부과학회
18. Hijnen DJ, "Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis", J Eur Acad Dermatol Venereol, 21, pp.85~89 (2007)
19. Schmitt J, "Cyclosporin in the treatment of patients with atopic eczema-a systematic review and meta-analysis", J Eur Acad Dermatol Venereol, 21, pp.606~619 (2007)
20. Bemanian MH, "High doses intravenous immunoglobulin versus oral cyclosporine in the treatment of severe atopic dermatitis", Iran J Allergy Asthma Immunol, 4, pp.139~143 (2005)
21. Granlund H, "Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis", Acta Derm Venereol, 81, pp.22~27 (2001)
22. Haeck IM, "Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis : a randomized controlled trial", J Am Acad Dermatol, 64, pp.1074~1084 (2011)
23. Ariëns LFM, "Dupilumab versus cyclosporine for the treatment of moderate-to-severe atopic dermatitis in adults : indirect comparison using the eczema area and severity index", Acta Derm Venereol, 99, pp.851~857 (2019)
24. Schneeweiss MC, "Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitis", J Am Acad Dermatol, 85, pp.321~329 (2021)
25. Schram ME, "A randomized trial of methotrexate versus azathioprine for severe atopic eczema", J Allergy Clin Immunol, 128, pp.353~359 (2011)
26. Gerbens LAA, "Methotrexate and azathioprine for severe atopic dermatitis : a 5-year follow-up study of a randomized controlled trial", Br J Dermatol, 178, pp.1288~1296 (2018)
27. Roekevisch E, "Methotrexate versus azathioprine in patients with atopic dermatitis : 2-year follow-up data", J Allergy Clin Immunol, 141, pp.825~827 (2018)
28. Goujon C, "Methotrexate versus cyclosporine in adults with moderateto-severe atopic dermatitis : a phase III randomized noninferiority trial", J Allergy Clin Immunol Pract, 6, pp.562~569 (2018)
29. Wollenberg A, "Consensus-based European guidelines for treatment of atopic eczema(atopic dermatitis)in adults and children : part II", J Eur Acad Dermatol Venereol, 32, pp.850~878 (2018)
30. Rajagopalan M, "Guidelines on management of atopic dermatitis in India: an evidence-based review and an expert consensus", Indian J Dermatol, 64, pp.166~181 (2019)
31. Berth-Jones J, "Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial", Br J Dermatol, 147, pp.324~330 (2002)
32. Meggitt SJ, "Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial", Lancet, 367, pp.839~846 (2006)
33. Caufield M, "Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring", J Am Acad Dermatol, 68, pp.29~35 (2013)
34. Hon KL, "Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults", J Dermatolog Treat, 20, pp.141~145 (2009)
35. Noguera-Morel L, "A retrospective study of systemic treatment of severe atopic dermatitis with azathioprine: effectiveness and tolerance in 11 pediatric patients", Actas Dermosifiliogr (Engl Ed), 110, pp.227~231 (2019)
36. Phan K, "Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis", J Dermatolog Treat, 31, pp.810~814 (2020)
37. Brunner PM, "The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies", J Allergy Clin Immunol, 139(4S), pp.S65~S76 (2017)
38. Simpson EL, "Two phase 3 trials of dupilumab versus placebo in atopic dermatitis", N Engl J Med, 375, pp.2335~2348 (2016)
39. Blauvelt A, "Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial", Lancet, 389, pp.2287~2303 (2017)
40. de Bruin-Weller M, "Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)", Br J Dermatol, 178, pp.1083~1101 (2018)
41. Snast I, "Are biologics efficacious in atopic dermatitis? A systematic review and meta-analysis", Am J Clin Dermatol, 19, pp.145~165 (2018)
42. Simpson EL, "Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis : a phase 3 randomized clinical trial", JAMA Dermatol, 156, pp.44~56 (2020)
43. Simpson EL, "Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: a randomized, placebo-controlled phase II trial (TREBLE)", J Am Acad Dermatol, 78, pp.863~871 (2018)
44. Wollenberg A, "Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb", J Allergy Clin Immunol, 143, pp.135~141 (2019)
45. Ruzicka T, "Anti-interleukin-31 receptor A antibody for atopic dermatitis", N Engl J Med, 376, pp.826~835 (2017)
46. Kabashima K, "Nemolizumab in patients with moderate-to-severe atopic dermatitis: randomized, phase II, long-term extension study", J Allergy Clin Immunol, 142, pp.1121~1130 (2018)
47. Oldhoff JM, "Anti-IL-5 recombinant humanized monoclonal antibody(mepolizumab)for the treatment of atopic dermatitis", Allergy, 60, pp.693~696 (2005)
48. Simpson EL, "Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial", J Am Acad Dermatol, 80, pp.1013~1021 (2019)
49. Guttman-Yassky E, "Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a randomized, double-blind, phase 2a trial", J Am Acad Dermatol, 78, pp.872~881 (2018)
50. Khattri S, "Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis", Exp Dermatol, 26, pp.28~35 (2017)
51. Wang HH, "Efficacy of omalizumab in patients with atopic dermatitis : a systematic review and meta-analysis", J Allergy Clin Immunol, 138, pp.1719~1722 (2016)
52. Sher LG, "Relieving the pruritus of atopic dermatitis : a meta-analysis", Acta Derm Venereol, 92, pp.455~461 (2012)
53. Wollenberg A, "Consensus-based European guidelines for treatment of atopic eczema(atopic dermatitis)in adults and children : part I", J Eur Acad Dermatol Venereol, 32, pp.657~682 (2018)
54. Matterne U, "Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczema", Cochrane Database Syst Rev, 1, pp.CD012167~ (2019)
55. Diepgen TL, "Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months", Pediatr Allergy Immunol, 13, pp.278~286 (2002)
56. Langeland T, "Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis. A multi-crossoverdesigned study", Allergy, 49, pp.22~26 (1994)
57. Kawashima M, "Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study", Br J Dermatol, 148, pp.1212~1221 (2003)
58. Yamanaka K, "Olopatadine, a non-sedating H1 antihistamine, decreases the nocturnal scratching without affecting sleep quality in atopic dermatitis", Exp Dermatol, 24, pp.227~229 (2015)
59. Gambichler T, "Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy", Br J Dermatol, 158, pp.1117~1120 (2008)
60. Pérez-Ferriols A, "Phototherapy in atopic dermatitis : a systematic review of the literature", Actas Dermosifiliogr, 106, pp.387~401 (2015)
61. Fernández-Guarino M, "Treatment of moderate and severe adult chronic atopic dermatitis with narrow-band UVB and the combination of narrow-band UVB", UVA phototherapy, 2016, pp.29, 19~23
62. Di Rienzo V, "Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study", Ann Allergy Asthma Immunol, 113, pp.671~673 (2014)
63. Galli E, "Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis", Allergol Immunopathol(Madr), 22, pp.18~22 (1994)
64. Glover MT, "A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema", Clin Exp Allergy, 22, pp.440~446 (1992)
65. Kaufman HS, "Hyposensitization with alum precipitated extracts in atopic dermatitis : a placebo-controlled study", Ann Allergy, 32, pp.321~330 (1974)
66. Leroy BP, "A novel therapy for atopic dermatitis with allergen-antibody complexes:a double-blind, placebo-controlled study", J Am Acad Dermatol, 28(2 Pt 1), pp.232~239 (1993)
67. Luna-Pech JA, "Efficacy of sublingual immunotherapy in the severity of atopic dermatitis in children with allergic sensitization to dermatophagoides pteronyssinus", Ann Allergy Asthma Immunol, 111, pp.A8~ (2013)
68. Novak N, "Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis", J Allergy Clin Immunol, 130, pp.925~931 (2012)
69. Pajno GB, "Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study", J Allergy Clin Immunol, 120, pp.164~170 (2007)
70. Qin YE, "Clinical efficacy and compliance of sublingual immunotherapy with Dermatophagoides farinae drops in patients with atopic dermatitis", Int J Dermatol, 53, pp.650~655 (2014)
71. Sánchez Caraballo JM, "Clinical and immunological changes of immunotherapy in patients with atopic dermatitis : randomized controlled trial", ISRN Allergy, 2012, pp.183983~ (2012)
72. Silny W, "Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study", Pol Merkur Lekarski, 21, pp.558~565 (2006)
73. Warner JO, "Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma", Lancet, 2, pp.912~915 (1978)
74. Bae JM, "Efficacy of allergenspecific immunotherapy for atopic dermatitis : a systematic review and meta-analysis of randomized controlled trials", J Allergy Clin Immunol, 132, pp.110~117 (2013)
75. Gendelman SR, "Specific immunotherapy in the treatment of atopic dermatitis : a systematic review using the GRADE system", Ann Allergy Asthma Immunol, 111, pp.555~561 (2013)
76. Gendelman SR, "Sublingual immunotherapy in the treatment of atopic dermatitis : a systematic review using the GRADE system", Curr Allergy Asthma Rep, 15, pp.498~ (2015)
77. Tam H, "Specific allergen immunotherapy for the treatment of atopic eczema", Cochrane Database Syst Rev, 2, pp.CD008774~ (2016)
78. Leyden JJ, "Staphylococcus aureus in the lesions of atopic dermatitis", Br J Dermatol, 90, pp.525~530 (1974)
79. Nomura I, "Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis", J Allergy Clin Immunol, 104(2 Pt 1), pp.441~446 (1999)
80. Cho SH, "Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model", J Invest Dermatol, 116, pp.658~663 (2001)
81. Bath-Hextall FJ, "Interventions to reduce Staphylococcus aureus in the management of atopic eczema : an updated Cochrane review", Br J Dermatol, 164, pp.228~ (2011)
82. Boguniewicz M, "Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis", J Allergy Clin Immunol, 108, pp.651~652 (2001)
83. Svejgaard El, "Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo", J Eur Acad Dermatol Venereol, 18, pp.445~449 (2004)
84. Wessels MW, "IgE antibodies to Pityrosporum ovale in atopic dermatitis", Br J Dermatol, 125, pp.227~232 (1991)
85. Lintu P, "Systemic ketoconazole is an effective treatment of atopic dermatitis with IgEmediated hypersensitivity to yeasts", Allergy, 56, pp.512~517 (2001)
86. Wollenberg A, "Viral infections in atopic dermatitis : pathogenic aspects and clinical management", J Allergy Clin Immunol, 112, pp.667~674 (2003)
87. Rosenfeldt V, "Effect of probiotic Lactobacillus strains in children with atopic dermatitis", J Allergy Clin Immunol, 111, pp.389~395 (2003)
88. Passeron T, "Prebiotics and synbiotics : two promising approaches for the treatment of atopic dermatitis in children above 2 years", Allergy, 61, pp.431~437 (2006)
89. Sistek D, "Is the effect of probiotics on atopic dermatitis confined to food sensitized children", Clin Exp Allergy, 36, pp.629~633 (2006)
90. Gerasimov SV, "Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial", Am J Clin Dermatol, 11, pp.351~361 (2010)
91. Woo SI, "Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome", Ann Allergy Asthma Immunol, 104, pp.343~348 (2010)
92. Wu KG, "Lactobacillus salivarius plus fructooligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a doubleblind, randomized, clinical trial of efficacy and safety", Br J Dermatol, 166, pp.129~136 (2012)
93. Yavuz Yeşilova, "Effect of Probiotics on the Treatment of Children with Atopic Dermatitis", Annals of Dermatology, 24(2), pp.189~193 (2012), 대한피부과학회[DOI]
94. Han Y, "A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis", Pediatr Allergy Immunol, 23, pp.667~673 (2012)
95. Viljanen M, "Probiotics in the treatment of atopic eczema", dermatitis syndrome in infants : a double-blind placebo-controlled trial, 2005, pp.60, 494~500
96. van der Aa LB, "Effect of a new synbiotic mixture on atopic dermatitis in infants : a randomized-controlled trial", Clin Exp Allergy, 40, pp.795~804 (2010)
97. Gore C, "Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema : randomized controlled trial with follow-up until age 3 years", Clin Exp Allergy, 42, pp.112~122 (2012)
98. Iemoli E, "Probiotics reduce gut microbial translocation and improve adult atopic dermatitis", J Clin Gastroenterol, 46(Suppl), pp.S33~S40 (2012)
99. Drago L, "Effects of Lactobacillus salivarius LS01(DSM 22775)treatment on adult atopic dermatitis : a randomized placebo-controlled study", Int J Immunopathol Pharmacol, 24, pp.1037~1048 (2011)
100. Majamaa H, "Probiotics : a novel approach in the management of food allergy", J Allergy Clin Immunol, 99, pp.179~185 (1997)
101. Weston S, "Effects of probiotics on atopic dermatitis : a randomised controlled trial", Arch Dis Child, 90, pp.892~897 (2005)
102. Fölster-Holst R, "Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis", Br J Dermatol, 155, pp.1256~1261 (2006)
103. Yoshida Y, "Clinical effects of probiotic bifidobacterium breve supplementation in adult patients with atopic dermatitis", Yonago Acta Med, 53, pp.37~45 (2010)
104. Chernyshov P., "Randomized, placebo-controlled trial on clinical and immunologic effects of probiotic containing Lactobacillus rhamnosus R0011 and L. helveticus R0052 in infants with atopic dermatitis", Microb Ecol Health Disease, 21, pp.228~232 (2009)
105. Cukrowska B, "Probiotic lactobacillus casei and lactobacillus paracasei strains in treatment of food allergy in children", Prz Pediatr, 40, pp.21~25 (2010)
106. Makrgeorgou A, "Probiotics for treating eczema", Cochrane Database Syst Rev, 11, pp.CD006135~ (2018)
107. Senapati S, "Evening primrose oil is effective in atopic dermatitis : a randomized placebo-controlled trial", Indian J Dermatol Venereol Leprol, 74, pp.447~452 (2008)
108. 정보영, "Effect of Evening Primrose Oil on Korean Patients With Mild Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Study", Annals of Dermatology, 30(4), pp.409~416 (2018), 대한피부과학회
109. Schalin-Karrila M, "Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins", Br J Dermatol, 117, pp.11~19 (1987)
110. Bamford JT, "Oral evening primrose oil and borage oil for eczema", Cochrane Database Syst Rev, 2013, pp.CD004416~ (2013)
111. Amestejani M, "Vitamin D supplementation in the treatment of atopic dermatitis : a clinical trial study", J Drugs Dermatol, 11, pp.327~330 (2012)
112. Javanbakht MH, "Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis", J Dermatolog Treat, 22, pp.144~150 (2011)
113. Camargo CA Jr, "Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children", J Allergy Clin Immunol, 134, pp.831~835 (2014)
114. Sidbury R, "Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston : a pilot study", Br J Dermatol, 159, pp.245~247 (2008)
115. Udompataikul M, "The effects of oral vitamin D supplement on atopic dermatitis : a clinical trial with staphylococcus aureus colonization determination", J Med Assoc Thai, 98(Suppl 9), pp.S23~S30 (2015)
116. Hata TR, "A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis", J Eur Acad Dermatol Venereol, 28, pp.781~789 (2014)
117. Kim MJ, "Vitamin D status and efficacy of vitamin D supplementation in atopic dermatitis : a systematic review and meta-analysis", Nutrients, 8, pp.789~ (2016)
118. Kim G, "Vitamin D and atopic dermatitis : a systematic review and meta-analysis", Nutrition, 32, pp.913~920 (2016)
119. Abrouk M, "Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses", J Am Acad Dermatol, 77, pp.177~180 (2017)
120. Farahnik B, "Use of an oral phosphodiesterase-4 inhibitor (apremilast) for the treatment of chronic, severe atopic dermatitis: a case report", Dermatol Online J, 23, pp.13030~ (2017)
121. Samrao A, "A pilot study of an oral phosphodiesterase inhibitor(apremilast)for atopic dermatitis in adults", Arch Dermatol, 148, pp.890~897 (2012)
122. Saporito RC, "Apremilast use for moderate-to-severe atopic dermatitis in pediatric patients", Case Rep Dermatol, 8, pp.179~184 (2016)
123. Simpson EL, "A phase 2 randomized trial of apremilast in patients with atopic dermatitis", J Invest Dermatol, 139, pp.1063~1072 (2019)
124. Volf EM, "A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis", J Drugs Dermatol, 11, pp.341~346 (2012)
125. Guttman-Yassky E, "Baricitinib in adult patients with moderate-tosevere atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study", J Am Acad Dermatol, 80, pp.913~921 (2019)
126. Levy LL, "Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate", J Am Acad Dermatol, 73, pp.395~399 (2015)
127. Murata Y, "Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis", J Dermatol, 42, pp.129~139 (2015)
128. Werfel T, "Efficacy and safety of the histamine H4 receptor antagonist ZPL3893787 in patients with atopic dermatitis", J Allergy Clin Immunol, 143, pp.1830~1837 (2019)
129. Walter M, "The histamine H₄ receptor : targeting inflammatory disorders", Eur J Pharmacol, 668, pp.1~5 (2011)
130. Gutzmer R, "The histamine H4 receptor is functionally expressed on T(H)2 cells", J Allergy Clin Immunol, 123, pp.619~625 (2009)
131. Mobasher P, "Oral small molecules for the treatment of atopic dermatitis : a systematic review", J Dermatolog Treat, 30, pp.550~557 (2019)
132. Narla S, "Inpatient financial burden of atopic dermatitis in the United States", J Invest Dermatol, 137, pp.1461~1467 (2017)
133. Weber MB, "Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups", J Eur Acad Dermatol Venereol, 22, pp.992~997 (2008)
134. 장용현, "A Family-Engaged Educational Program for Atopic Dermatitis: A Seven-Year, Multicenter Experience in Daegu-Gyeongbuk, South Korea", Annals of Dermatology, 27(4), pp.383~388 (2015), 대한피부과학회
135. Lambert J, "A novel multidisciplinary educational programme for patients with chronic skin diseases : Ghent pilot project and first results", Arch Dermatol Res, 303, pp.57~63 (2011)
136. Heratizadeh A, "Effects of structured patient education in adults with atopic dermatitis : Multicenter randomized controlled trial", J Allergy Clin Immunol, 140, pp.845~853 (2017)

관련 논문AI추천